A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Telerehabilitation in Hemato-oncological Survivors
- Status
- RECRUITING
- Phase
- NA
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
- Status
- COMPLETED
- Phase
- NA
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
- Status
- COMPLETED
- Phase
- N/A
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Status
- RECRUITING
- Phase
- NA
First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
- Status
- RECRUITING
- Phase
- N/A
Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access to Epcoritamab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Improving Patient Experience: BMBA
- Status
- COMPLETED
- Phase
- NA
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Penpulimab in Maintenance Therapy in Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- Status
- RECRUITING
- Phase
- NA
A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Status
- RECRUITING
- Phase
- N/A
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
- Status
- TERMINATED
- Phase
- NA